12/4
09:00 am
drts
Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium
Low
Report
Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium
12/2
09:00 am
drts
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer
Medium
Report
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer
12/1
09:13 am
drts
Alpha Tau to Participate in December Investor Conferences [Yahoo! Finance]
Medium
Report
Alpha Tau to Participate in December Investor Conferences [Yahoo! Finance]
12/1
09:00 am
drts
Alpha Tau to Participate in December Investor Conferences
Medium
Report
Alpha Tau to Participate in December Investor Conferences
11/24
08:06 am
drts
Alpha Tau Medical (NASDAQ:DRTS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Medium
Report
Alpha Tau Medical (NASDAQ:DRTS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
11/20
04:20 pm
drts
Alpha Tau Medical GAAP EPS of -$0.39 [Seeking Alpha]
High
Report
Alpha Tau Medical GAAP EPS of -$0.39 [Seeking Alpha]
11/20
04:05 pm
drts
Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update
High
Report
Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update
11/11
08:30 am
drts
Alpha Tau to Participate at Jefferies Global Healthcare Conference in London
Medium
Report
Alpha Tau to Participate at Jefferies Global Healthcare Conference in London
11/1
01:05 am
drts
Alpha Tau Medical (NASDAQ:DRTS) was upgraded by analysts at
Wall Street
Medium
Report
Alpha Tau Medical (NASDAQ:DRTS) was upgraded by analysts at
Wall Street
10/22
10:49 am
drts
Alpha Tau Medical (NASDAQ:DRTS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Medium
Report
Alpha Tau Medical (NASDAQ:DRTS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
10/21
08:30 am
drts
Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness
Medium
Report
Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness
10/16
11:57 am
drts
Alpha Tau Medical: Localized Alpha Radiation, A New Paradigm In Oncology [Seeking Alpha]
Low
Report
Alpha Tau Medical: Localized Alpha Radiation, A New Paradigm In Oncology [Seeking Alpha]